GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Pre-Tax Income

SER (Serina Therapeutics) Pre-Tax Income : $-5.63 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Serina Therapeutics's pretax income for the three months ended in Dec. 2024 was $-2.75 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-5.63 Mil. Serina Therapeutics's pretax margin was %.

During the past 4 years, Serina Therapeutics's highest Pretax Margin was 175.63%. The lowest was -536.40%. And the median was -41.63%.

Serina Therapeutics Pre-Tax Income Historical Data

The historical data trend for Serina Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Pre-Tax Income Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
-1.27 -2.68 5.27 -11.21

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 -9.44 5.18 1.38 -2.75

Competitive Comparison of Serina Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Serina Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Serina Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's Pre-Tax Income falls into.


;
;

Serina Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Serina Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-17.048+6.367+-0.526+0+-3.5527136788005E-15
=-11.21

Serina Therapeutics's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-5.549+2.814+-0.017+0+8.8817841970013E-16
=-2.75

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Serina Therapeutics  (AMEX:SER) Pre-Tax Income Explanation

Serina Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-2.752/0
=%

During the past 4 years, Serina Therapeutics's highest Pretax Margin was 175.63%. The lowest was -536.40%. And the median was -41.63%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Serina Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Pre-Tax Income
Comparable Companies
FBRX ADAP STTK CTMX KRON GANX MGX ALVR ALGS DTIL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.